Nestle gets closer to Seres, pledging $525m for microbiome C. diff drugSwiss food giant Nestle has firmed up its five-year-old alliance with US microbiome specialist Seres, paying $175 million Share XNestle gets closer to Seres, pledging $525m for microbiome C. diff drughttps://pharmaphorum.com/news/nestle-gets-closer-to-seres-pledging-525m-for-microbiome-c-diff-drug/
Good data supports pharma sales reps to drive lead generationAllow pharma sales reps to focus on the job in hand by making sure they have access to Share XGood data supports pharma sales reps to drive lead generationhttps://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
